How Rescheduling Hydrocodone Combination Products Will Reduce Abuse

Published Online: Wednesday, January 22, 2014
Follow Pharmacy_Times:
In this video, Mary Lynn McPherson, PharmD, professor and vice chair at the University of Maryland School of Pharmacy, explains how rescheduling hydrocodone combination products as Schedule II drugs will help reduce levels of abuse.
 
This is the seventh in a series of videos in which Dr. McPherson argues in favor of categorizing hydrocodone combination products as Schedule II drugs, and Jeff Fudin, PharmD, argues against doing so. (Drs. McPherson and Fudin were assigned to take these positions for a session at the American Society of Health-System Pharmacists 2013 Midyear Clinical Meeting in Orlando, and their arguments do not necessarily reflect their personal positions on the issue.)
 
These videos were filmed at the ASHP 2013 Midyear Clinical Meeting in Orlando.

Related Articles
Responding to the growing number of deaths related to prescription opioid overdose, the US Department of Health and Human Services recently announced new opioid abuse countermeasures.
Daniel Abazia, PharmD, BCPS, clinical assistant professor at Ernest Mario School of Pharmacy, talks about a pharmacist's legal responsibility when a controlled substance is dispensed.
Daniel Abazia, PharmD, BCPS, clinical assistant professor at Ernest Mario School of Pharmacy, talks about how the prevalence and severity of opioid abuse has increased in the last decade.
This year's pharmacy residency matches have been released, stirring up emotions ranging from sheer satisfaction to dread and panic.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$